600521.SH
华海药业
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 16.20
−2.53%Margins
Gross margin
58.2%
EBITDA margin
17.3%
EBIT margin
6.1%
Net margin
4.4%
FCF margin
-6.9%
3.8%
Return on equity
1.7%
Return on assets
3.4%
Return on invested capital
0.39x
Asset turnover
CNY 1.4B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026